Top News - Tobacco Reporter

Red Man Rebrands as America’s Best Chew

Swedish Match is rebranding its Red Man chewing tobacco to America’s Best Chew to better align with the company’s contemporary values. The name change comes as the product celebrates its 135th anniversary.

While the new packaging will reflect the rebrand, the product is the same. According to Swedish Match, consumers can expect the same high-quality chewing tobacco that has been enjoyed by generations, right down to the unmistakable aroma, texture and flavor.

“Understanding that an essential part of being America’s best means being a leader, Swedish Match worked diligently over the past several months to make changes in response to our heightened awareness and our desire to be more inclusive,” said Joe Ackerman, vice president of marketing at Swedish Match, in a statement. “Consumers and diverse agency partners were selected to participate in the rebranding research. It was critical and valuable for us to gain these insights and recommendations to develop America’s Best Chew packaging.”

“I applaud the Swedish Match company for retiring the use of ‘Red Man’ as a product name,” said Cherokee Nation Principal Chief Chuck Hoskin, Jr. “Nationally, we are moving away from the use of derogatory terms and depictions of Native Americans as product mascots because representations are stereotypical caricatures, and they do not honor us or reflect how we live and thrive, both as individuals and as unique Tribal Nations today. The announcement to change the brand’s name and imagery gives us hope that more companies, schools and sports teams hear us and that we will continue to make impactful national changes for the betterment of Indian Country.”

“This decision exemplifies the global awakening of these harmful practices toward Indigenous Peoples and gives us hope that others will follow Swedish Match’s bold and courageous lead,” said Fawn Sharp, president of the National Congress of American Indians.

“While the phrase ‘America’s Best Chew’ may have gone unnoticed to some, it is an essential part of who we are,” according to Ackerman. “It represents our founder John Pinkerton’s passion and commitment to quality. More importantly, America’s Best Chew was the promise that Pinkerton made 135 years ago when he created the original recipe and innovative flavoring process that we still use today.”

The transition to the new America’s Best Chew packaging will begin within the next few weeks.

January 21, 2022

Tobacco Firms Recognized as Top Employers

BAT, Japan Tobacco International and Imperial Brands have been named as top employers by the Top Employers Institute.

“Being named as a Global Top Employer for the fifth year in a row is a recognition of BAT’s inclusive, engaging culture and innovative working environment,” said Hae In Kim, director of talent, culture and inclusion at BAT, in a statement. “We are continually striving to maintain a workplace where employees feel empowered and well supported, and we are delighted this has been recognized.

“It is an honor to once again be certified by Top Employers Institute,” said Howard Parks, JTI’s senior vice president of people and culture, in a press note. “Our people are at the heart of everything we do, which is why we aim to offer them the best possible working environment. Giving our over 40,000 colleagues the opportunity to grow and providing them with the optimal conditions and support to fulfil their potential is of paramount importance to us.”

“I am delighted that Imperial has been recognized as a Top Employer for another year,” said Alison Clarke, Imperial’s chief people and culture officer, in a statement. “Imperial Brands is a great place to work, grow and develop, and it’s particularly pleasing that—in these challenging times when we can’t always congregate in the way we would like—our people have shown real resilience and embraced new ways of engaging to create an even better place to work.”

The Top Employer certification process is conducted annually by the Top Employers Institute, an independent organization that studies the employee offerings of major employers around the world. Certification recognizes employers that provide best-in-class employment practices, allowing employees to develop themselves personally and professionally while driving business results. Participating companies undergo a rigorous assessment process, which includes an extensive review of employer practices. Several validation sessions are held where evidence of these practices is provided, and an independent audit of the findings is also carried out.

January 20, 2022

Zimbabwe Leaf Earnings Up

Zimbabwe has earned more than $80 million from tobacco exports to date this season, up from a little over $17 million during the same period of the prior year, reports The Herald. The country has exported 15,777 tons so far compared with 573 tons in the comparable period of the previous selling season.

Industry representatives attribute the jump to the timing of shipments. According to the Tobacco Industry and Marketing Board (TIMB), companies with customers in the Far East have moved their tobacco to ports in South Africa earlier than normal to secure space on vessels.

“During the same period last year, due to the Covid[-19] pandemic, efficient shipment of goods was affected as some shipping lines canceled their vessels,” said TIMB spokesperson Chelesani Moyo.

The Far East was the top destination for Zimbabwean tobacco, with local companies exporting 190,153 tons worth $67.5 million to date.

The Middle East imported 2,614 tons worth $6,49 million while the European Union bought 1,543 tons worth $3.71 million. African countries imported 927 tons worth $2.06 million, and the Americas bought 14 tons valued at $1.73 million, according to the TIMB.

More than 140,000 farmers now engage in tobacco production while close to 1 million people are directly dependent on the golden leaf.

Tobacco generates 30 percent of Zimbabwe’s foreign currency earnings, bringing in more than $600 million annually.

To learn more about the impact of Covid-19 on global tobacco shipments, see “Taking Freight,” in this month’s issue of Tobacco Reporter.

January 20, 2022

FDA Urged to Act on Remaining Applications

Several anti-tobacco groups have sent a letter to the U.S. Food and Drug Administration urging the agency to act on the outstanding premarket tobacco product applications (PMTAs) and pushing for the denial of all flavored e-cigarette products.

It’s been more than four months since the FDA was supposed to decide which e-cigarette products can remain on the market, but the agency still hasn’t completed some of the reviews, including some of the bestselling e-cigarettes.

“We write to urge the U.S. Food and Drug Administration (FDA) to expedite decisions on the premarket tobacco product applications (PMTAs) still pending before the agency involving the flavored e-cigarette products, including those with menthol flavoring and, based on the best available scientific evidence, deny the pending applications for all nontobacco flavored e-cigarettes in order to protect the nation’s young people from the health harms of these products,” the letter said.

The letter was signed by the American Academy of Pediatrics, the American Heart Association and the Campaign for Tobacco-Free Kids, among others.

“Every day that FDA delays action, more of our kids remain at risk,” said Matthew Myers, president of the Campaign for Tobacco-Free Kids. “While the FDA has ruled on applications from a lot of small companies, it hasn’t ruled on the applications from the large companies whose products are being used by a majority of kids.”

American Vaping Association President Gregory Conley pointed to data showing that youth vaping has been declining. According to the Centers for Disease Control and Prevention (CDC), use of e-cigarettes went down among middle school and high school students from 2019 to 2020.

But even with the drop, the CDC said it “estimated that more than 2 million U.S. middle [school] and high school students reported currently using e-cigarettes in 2021.”

January 20, 2022

Lithuania Bans Flavored E-Cigarettes

Lithuania will ban the sale of flavored e-cigarettes and e-liquid cartridges starting in July, reports LRT. Tobacco flavors will remain legal.

The move is aimed at reducing sales of e-cigarettes that are growing increasingly popular in Lithuania.

On Jan. 18, Lithuanian lawmakers adopted amendments to the Law on Control of Tobacco, Tobacco Products and Related Products with 92 votes in favor, nine against and nine abstentions.

Lithuania already bans e-cigarettes and e-liquid cartridges containing vitamins and other additives that create an impression that they are good or do less damage to health.

The country also prohibits imports of e-cigarettes and e-liquid cartridges containing caffeine and other stimulating compounds linked to energy and vitality.

January 20, 2022

P&K Presents New Brand Strategy

Phillips & King International has announced a new brand identity and wholesale e-commerce platform.

A contemporary refinement of the company’s “shield and knight” badge, the new logo signifies Phillips & King’s mission to modernize the business while paying homage to its 116-year history.

Phillips & King has embarked on a complete digital transformation of its business to better serve the evolving needs of its retail customers and brand partners. Over the course of this year, the company will be launching a host of enhancements to its business, including a new web platform expected to launch in the second quarter that will make it easier for stores to discover and stock products. Phillips & King will also be expanding its product and category assortment to give emerging brands the ability to reach more buyers.

“The future of B2B wholesale commerce is both digital and highly personalized,” says Jason Carignan, president of Phillips & King. “Our new web platform will enable us to more easily connect buyers and sellers across the industry and offer a more expansive array of products and categories—all while improving the personal connection our sales teams have with customers.

“We believe that retailers should be able to manage their entire business with ease from their mobile device and have access to business intelligence—and expert guidance—that helps drive inventory-buying decisions. This new platform is the first step in our quest to helping stores thrive in the new retail reality.”

Phillips & King is a subsidiary of Kretek International.

January 20, 2022

BAT Launches Virtual R&D Visitor Experience

BAT has created a virtual R&D visitor experience, an online tour of its global research and development hub in Southampton, U.K., that allows people to explore its cutting-edge science and innovation.

BAT says the experience builds on the company’s open and transparent approach to the science underpinning its reduced-risk product portfolio and beyond nicotine activities. The company regularly welcomes visitors in person to its global R&D hub, with more than 3,500 people viewing the facilities firsthand since 2011. However, with travel significantly reduced, the virtual experience allows people from across the globe to access and understand BAT’s scientific research and tobacco harm reduction activities and gain perspectives and insights from experts.

“At BAT, R&D is fundamental to what we do,” said David O’Reilly, director of scientific research at BAT, in a statement. “Our focus on science and research has enabled us to make significant progress in developing and evolving our New Category products, which are rigorously tested and scientifically substantiated as reduced-risk alternatives to cigarettes. Our R&D is based around consumer preferences as well as applying evolving science and innovation to our products. This allows us to offer a range of enjoyable reduced-risk alternatives to cigarettes while ensuring we maintain very high safety and quality standards.

“Our new R&D virtual visitor experience demonstrates the breadth of science we are undertaking and the robust scientific framework we use to evaluate and support the role our products play in delivering tobacco harm reduction.”

With 360-degree lab tours, animations, videos, scientist profiles, podcasts and more, the R&D virtual visitor experience is the one-stop hub for those looking to find out about BAT’s science. The tour illuminates BAT’s purpose to build “A Better Tomorrow” and mission to reduce the health impact of its business. BAT invests almost £350 million [$477.18 million] a year to find innovative ways to reduce its effects on public health and aims to have 50 million consumers of its noncombustible products by 2030.

January 19, 2022

Malaysia Mulls Age-Based Tobacco Ban

Malaysian Health Minister Khairy Jamaluddin wants to ban smoking for the next generation of Malaysians, according to reports by Lowyat and Code Blue. The plan comes in the wake of New Zealand’s announcement that it would prohibit the sale of cigarettes to anyone born after 2008.

Jamaluddin plans to table a new Tobacco and Smoking Control Act at the upcoming Parliament meeting from Feb. 28 to March 24, which will replace the current tobacco product control legislation under the Food Act 1983.

The bill will also regulate e-cigarettes and vape products, according to Jamaluddin, who called the bill a “generation endgame.”

“For too long, our healthcare system has been burdened with healthcare issues resulting from smoking,” said Jamaluddin. “This allocation will enable smoking to be phased out in stages until one day in [the] future, Malaysia will be a smoke-free country.”

A date for the proposed legislation has not been specified nor has a cutoff year of birth for the cohort smoking ban.

January 19, 2022

New Habanos Website

Corporacion Habano has redesigned its website with the input from distributors and cigar aficionados. The new website allows users to easily find information about brands, events and new developments. The site’s popular authenticity check function has been improved.

The site also features a section that allows aficionados to easily locate places where Habanos cigars can be purchased or smoked.

“Habanos has opted for a much more visual style, faithful to its elegant and exquisite essence, trying the Habanos aficionados to find everything they need and enjoy browsing and learning more about the rich culture surrounding this exclusive product,” said Habanos Deputy Director of Operational Marketing Alex Fernandez Blanco Barrero.

A global leader in the commercialization of premium cigars, Corporacion Habano has an exclusive distribution network spread over five continents and more than 150 countries.

January 19, 2022

Respira Creates Science Advisory Board

Respira Technologies has created a scientific advisory board and appointed Jasjit S. Ahluwalia as its chair.

According to Respira, the scientific advisory board plans to strengthen the company’s connection to the constantly evolving body of scientific evidence on the issues of tobacco use, harm reduction, nicotine and smoking cessation being generated by public health to guide the development of its technology and pipeline for current and future new drug applications.

“As a biotechnology company whose goal is to end the death and disease caused by smoking through the development of a breakthrough smoking cessation therapy, we must be guided by and have a deep understanding of the constantly evolving data and science generated by public health on issues important to our business,” said Respira Technologies CEO Mario Danek in a statement.

“We are thrilled to name Dr. Ahluwalia as chair and the founding member of our scientific advisory board. He represents one of the best and brightest scientific minds with decades of experience in studying nicotine addiction and cessation. Having guidance and perspective from the most distinguished researchers in this space will be critical to Respira achieving its goal of contributing to eliminating preventable morbidity and mortality and achieving health equity.”

Ahluwalia is a leader in academic research and public health focused on studying tobacco use, nicotine addiction and smoking cessation. He is a physician and public health scientist at Brown University.

Through his research, he has also investigated issues of health disparities and minority health broadly across multiple areas of substance use, cancer prevention and public health.

At Brown University, he is a professor, associate director of the Legoretta Cancer Center and deputy director of the Center for Addiction and Disease Risk Exacerbation, a NIH-funded Center of Biomedical Research Excellence. Ahluwalia’s work has generated over 350 publications in leading scientific journals, and he has received over $100 million in research funding as a principal and co-investigator.

As chair of Respira’s Scientific Advisory Board, Ahluwalia will be engaged in the company’s scientific strategy, development of clinical research and leading engagement within the nicotine, addiction and cessation public health community. His broad healthcare research background will guide Respira’s current application and inform the company’s development pipeline to expand application of its proprietary drug delivery platform across a diverse spectrum of indications and patient populations.

“I have dedicated the last 30 years of my career to understanding nicotine addiction, cessation and the complex issues they create in our society, especially among ethnic minority and other vulnerable populations,” said Ahluwalia. “Respira has the potential to create a very significant impact on this important public health crisis. I am thrilled to be leading Respira’s scientific advisory board and look forward to assisting the company in its efforts to improve the lives of hundreds of millions of smokers looking to quit around the world.”

Respira Technologies is preparing to submit an investigative new drug application to the U.S. Food and Drug Administration in 2022, which will allow the company to begin human clinical studies. The company is pursuing a prescription designation for its portable handheld combination drug device for the indication of smoking cessation therapy.

January 19, 2022

Category: Top News